Skip to main content Back to Top


Chorionic Gonadotropin (Human) for Injection

Products Affected - Description

    • Pregnyl injection, Merck, 10,000 unit, multiple dose vial, 1 count, NDC 00052-0315-10

Reason for the Shortage

    • Merck states their product is on allocation to prevent use in the gray market.

Available Products

    • Novarel injection, Ferring, 10,000 unit, multiple dose vial, 1 count, NDC 55566-1501-01
    • Chorionic Gonadotropin (Human) injection, Fresenius Kabi, 10,000 unit, multiple dose vial, 10 count, NDC 63323-0025-10

Estimated Resupply Dates

    • Merck has Pregnyl injection on allocation. Place orders through your wholesaler.
    • Fresenius Kabi and Ferring have product readily available.


Updated November 25, 2019 by Megan Dryer, PharmD. Created January 29, 2008 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins